Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
- PMID: 10675212
- PMCID: PMC1736814
- DOI: 10.1136/jnnp.68.3.313
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
Abstract
Objectives: To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.
Methods: We scanned nine humans exposed to MPTP with parkinsonism ranging from minimal to severe using [(18)F]fluorodopa (FD) and high resolution PET. The results were compared with those of 10 patients with Parkinson's disease and six normal subjects.
Results: In the MPTP group there was an equal degree of reduction of dopaminergic function in the caudate and putamen. This was different from the greater putaminal than caudate loss in Parkinson's disease (p<0.001).
Conclusions: Parkinson's disease is not caused by transient exposure to MPTP.
Comment in
-
Pattern of dopaminergic loss in the striatum of humans with parkinsonism induced by MPTP.J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):276. doi: 10.1136/jnnp.68.3.276. J Neurol Neurosurg Psychiatry. 2000. PMID: 10675207 Free PMC article. No abstract available.
Similar articles
-
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.Ann Neurol. 1994 Nov;36(5):765-70. doi: 10.1002/ana.410360513. Ann Neurol. 1994. PMID: 7979223
-
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).N Engl J Med. 1992 Nov 26;327(22):1556-63. doi: 10.1056/NEJM199211263272203. N Engl J Med. 1992. PMID: 1435882 Clinical Trial.
-
The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.Neurosci Lett. 1988 Oct 5;92(2):228-33. doi: 10.1016/0304-3940(88)90066-3. Neurosci Lett. 1988. PMID: 3263594
-
[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].Neurologia. 1991 Oct;6(8):287-94. Neurologia. 1991. PMID: 1790005 Review. Spanish.
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
Cited by
-
Contributions of the striatum to learning, motivation, and performance: an associative account.Trends Cogn Sci. 2012 Sep;16(9):467-75. doi: 10.1016/j.tics.2012.07.007. Epub 2012 Aug 10. Trends Cogn Sci. 2012. PMID: 22890090 Free PMC article. Review.
-
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Arch Toxicol. 2018 Jan;92(1):41-82. doi: 10.1007/s00204-017-2133-4. Epub 2017 Dec 5. Arch Toxicol. 2018. PMID: 29209747 Free PMC article. Review.
-
Glial cell response: A pathogenic factor in Parkinson's disease.J Neurovirol. 2002 Dec;8(6):551-8. doi: 10.1080/13550280290100905. J Neurovirol. 2002. PMID: 12476349 Review.
-
CAV-2-Mediated GFP and LRRK2G2019S Expression in the Macaca fascicularis Brain.Front Mol Neurosci. 2020 Mar 25;13:49. doi: 10.3389/fnmol.2020.00049. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32269512 Free PMC article.
-
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.J Neurosci. 2001 Sep 1;21(17):6853-61. doi: 10.1523/JNEUROSCI.21-17-06853.2001. J Neurosci. 2001. PMID: 11517273 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources